Epidermal Growth Factor Activates Protein Kinase C in the Human Endometrial Cancer Cell Line HEC-1-A

By Connor P.   Talavera F.   Kang J.-S.   Burke J.   Roberts J.   Menon K.M.J.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 46-50

Elsevier

Access to resources Recommend Favorite

Platelet-Activating Factor Enhances Production of Insulin-like Growth Factor Binding Proteins in a Human Adenocarcinoma Cell Line (HEC-1A)

By Giannini S.   Maggi M.   Cresci B.   Finetti G.   Bonaccorsi L.   Luconi M.   Rotella C.M.   Forti G.   Serio M.   Baldi E.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 333-340

Academic Press

Access to resources Recommend Favorite

Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells

By Tanaka Tetsuji   Toujima Saori   Tanaka Junko  

International Journal of Oncology, Vol. 41, Iss. 5, 2012-11 ,pp. : 1837-1844

Spandidos Publications

Access to resources Recommend Favorite

In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 464-470

Spandidos Publications

Access to resources Recommend Favorite

Short- and Long-term Oestradiol Treatment Inhibits Growth and Alters Expression of p21 WAF1Cip1 in an Endometrial Adenocarcinoma Cell Line Lacking Functional p53

By Karlsson L.   Delle U.   Horvath G.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2252-2257

Elsevier

Access to resources Recommend Favorite